Pericyte-derived exosomal hexokinase 2 promotes retinal neovascularization via non-metabolic ELK3 upregulation
Pathological retinal neovascularization (RNV) is a major cause of vision loss, driven by hypoxia-induced vascular endothelial growth factor (VEGF) upregulation. Although anti-VEGF therapies help, drug resistance suggests other mechanisms at play.